US 12,263,181 B2
Phospholipid compositions
Jakub D. Staszak-Jirkovsky, Denver, CO (US); Lukas Kobr, Denver, CO (US); Gregory Miknis, Broomfield, CO (US); Colleen Hudson, Denver, CO (US); Luca Monfregola, Denver, CO (US); Pavel Jirkovsky, Praha-Čimice (CZ); Zbončáková Milada, Lovosice (CZ); Jason Duex, Denver, CO (US); and Pitchaimani Kandasamy, Denver, CO (US)
Assigned to MACHAVERT PHARMACEUTICALS LLC, Aurora, CO (US)
Filed by MACHAVERT PHARMACEUTICALS LLC, Aurora, CO (US)
Filed on Aug. 22, 2022, as Appl. No. 17/892,782.
Application 17/892,782 is a continuation of application No. 16/653,591, filed on Oct. 15, 2019, granted, now 11,433,085.
Application 16/653,591 is a continuation of application No. 15/637,126, filed on Jun. 29, 2017, granted, now 10,493,086, issued on Dec. 3, 2019.
Claims priority of provisional application 62/356,197, filed on Jun. 29, 2016.
Claims priority of provisional application 62/356,189, filed on Jun. 29, 2016.
Prior Publication US 2022/0409641 A1, Dec. 29, 2022
Int. Cl. A61K 31/685 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 31/688 (2006.01); A61K 35/57 (2015.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01)
CPC A61K 31/688 (2013.01) [A61K 9/0053 (2013.01); A61K 9/48 (2013.01); A61K 31/685 (2013.01); A61K 35/57 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61K 2236/00 (2013.01)] 1 Claim
 
1. A method of treating leukemia in a human patient in need thereof comprising administering to said patient a pharmaceutical composition consisting of a plurality of phosphatidylcholine compounds and one or more pharmaceutically acceptable diluents, excipients, and/or carriers: wherein said plurality of phosphatidylcholine compounds comprise 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine and one or more phosphatidylcholines selected from the group consisting of:
1-palmitoleoyl-2-linoleoyl-sn-glycero-3-phosphocholine,
1-palmitoyl-2-α-linolenoyl-sn-glycero-3-phosphocholine,
1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine,
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine,
1-α-linolenoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine,
1-palmitoleoyl-2-oleoyl-sn-glycero-3-phosphocholine,
1-palmitoleoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine,
1-palmitoyl-2-osbodnoyl-sn-glycero-3-phosphocholine,
1-oleoyl-2-arachidonoyl-sn-glycero-3-phosphocholine,
1-oleoyl-2-linoleoyl-sn-glycero-3-phosphocholine,
1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine,
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine,
1-oleoyl-2-docosahexenoyl-sn-glycero-3-phosphocholine,
1,2-dioleoyl-sn-glycero-3-phosphocholine,
1-stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine, and
1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine.